| Health Care Technology Industry | Healthcare Sector | - CEO | HKEX Exchange | - ISIN |
| China Country | 370 Employees | - Last Dividend | - Last Split | - IPO Date |
Cryofocus Medtech (Shanghai) Co., Ltd. is a pioneering medical device company focused on the development, manufacturing, and distribution of minimally invasive interventional cryotherapy products. The company plays a critical role in addressing a variety of cardiovascular and other significant health conditions through its innovative solutions. Established in 2013, Cryofocus Medtech is dedicated to improving patient outcomes and elevating the standard of care in the People's Republic of China. It specializes in creating cutting-edge technology for vascular interventional therapy aimed at treating atrial fibrillation, hypertension, and other cardiovascular diseases, as well as natural orifice transluminal endoscopic surgery for urinary, respiratory, and digestive diseases.
Bladder Cryoablation System: A state-of-the-art cryotherapy device engineered for the treatment of non-muscle-invasive bladder cancer. This innovative system offers a minimally invasive solution, aiming to reduce patient discomfort and recovery time compared to traditional treatment methods. The Bladder Cryoablation System represents a significant advancement in cancer care, providing a targeted approach to tumor treatment while minimizing damage to surrounding healthy tissue.
Endoscopic Clip for Anastomosis: An anastomotic device designed for the precise and secure closure of soft tissue within the digestive tract. This product is vital for procedures requiring the joining of tissue or organs, ensuring a seamless healing process post-surgery. The Endoscopic Clip for Anastomosis plays a crucial role in gastrointestinal surgeries, offering an innovative solution that promotes faster recovery and reduces the risk of complications associated with traditional suturing techniques.